The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Price, Michael, Dr
    Doctor born in June 1975
    Individual (2 offsprings)
    Officer
    2023-04-01 ~ dissolved
    OF - Director → CIF 0
  • 2
    8, Dalton Square, Lancaster, England
    Active Corporate (5 parents, 1 offspring)
    Equity (Company account)
    -328,168 GBP2024-03-31
    Officer
    2018-04-19 ~ dissolved
    OF - Director → CIF 0
    Person with significant control
    2018-04-19 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 12
  • 1
    Gallagher, Andrew Robert, Doctor
    Doctor born in July 1962
    Individual (1 offspring)
    Officer
    2013-10-29 ~ 2018-04-19
    OF - Director → CIF 0
  • 2
    Carruthers, Richard Anthony, Dr
    Doctor born in March 1974
    Individual (1 offspring)
    Officer
    2014-09-01 ~ 2018-04-19
    OF - Director → CIF 0
  • 3
    Nightingale, Peter Bryan, Dr
    Doctor born in July 1959
    Individual (1 offspring)
    Officer
    2014-01-03 ~ 2018-04-19
    OF - Director → CIF 0
  • 4
    Mills, Emily Claire, Dr
    Doctor born in January 1979
    Individual (1 offspring)
    Officer
    2014-01-03 ~ 2018-04-19
    OF - Director → CIF 0
  • 5
    Torr, Gavin Bruce, Dr
    Doctor born in May 1972
    Individual (3 offsprings)
    Officer
    2013-10-29 ~ 2018-04-19
    OF - Director → CIF 0
  • 6
    Bass, Jane Dorothy, Dr
    Doctor born in September 1978
    Individual (1 offspring)
    Officer
    2015-02-01 ~ 2018-04-19
    OF - Director → CIF 0
  • 7
    Kingcox, Bridget
    Nurse born in November 1967
    Individual (1 offspring)
    Officer
    2014-04-01 ~ 2018-04-19
    OF - Director → CIF 0
  • 8
    Fairhurst, Howard John, Doctor
    Doctor born in October 1966
    Individual
    Officer
    2018-04-19 ~ 2023-03-31
    OF - Director → CIF 0
  • 9
    Smith, Iain Graham, Dr
    Doctor born in April 1976
    Individual (1 offspring)
    Officer
    2014-01-03 ~ 2018-04-19
    OF - Director → CIF 0
  • 10
    Braddock, Lesley, Dr
    Doctor born in April 1970
    Individual (1 offspring)
    Officer
    2014-01-03 ~ 2018-04-19
    OF - Director → CIF 0
  • 11
    Mcclelland, Averil, Dr
    Doctor born in April 1958
    Individual
    Officer
    2014-01-03 ~ 2015-01-31
    OF - Director → CIF 0
  • 12
    Keith, Rahul, Dr
    Doctor born in March 1982
    Individual (2 offsprings)
    Officer
    2014-01-03 ~ 2018-04-19
    OF - Director → CIF 0
parent relation
Company in focus

ROSEBANK PHARMA LIMITED

Standard Industrial Classification
86210 - General Medical Practice Activities
Brief company account
Property, Plant & Equipment
9,559 GBP2021-03-31
8,134 GBP2020-03-31
Total Inventories
21,333 GBP2021-03-31
21,597 GBP2020-03-31
Debtors
203,272 GBP2021-03-31
242,425 GBP2020-03-31
Cash at bank and in hand
85,651 GBP2021-03-31
24,366 GBP2020-03-31
Current Assets
310,256 GBP2021-03-31
288,388 GBP2020-03-31
Creditors
Current, Amounts falling due within one year
-272,561 GBP2021-03-31
-297,164 GBP2020-03-31
Net Current Assets/Liabilities
37,695 GBP2021-03-31
-8,776 GBP2020-03-31
Total Assets Less Current Liabilities
47,254 GBP2021-03-31
-642 GBP2020-03-31
Net Assets/Liabilities
45,438 GBP2021-03-31
-642 GBP2020-03-31
Equity
Called up share capital
102 GBP2021-03-31
102 GBP2020-03-31
Retained earnings (accumulated losses)
45,336 GBP2021-03-31
-744 GBP2020-03-31
Equity
45,438 GBP2021-03-31
-642 GBP2020-03-31
Average Number of Employees
72020-04-01 ~ 2021-03-31
92019-04-01 ~ 2020-03-31
Property, Plant & Equipment - Gross Cost
Other
36,137 GBP2021-03-31
31,292 GBP2020-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
26,578 GBP2021-03-31
23,158 GBP2020-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
3,420 GBP2020-04-01 ~ 2021-03-31
Property, Plant & Equipment
Other
9,559 GBP2021-03-31
8,134 GBP2020-03-31
Trade Debtors/Trade Receivables
Current
173,846 GBP2021-03-31
217,568 GBP2020-03-31
Other Debtors
Amounts falling due within one year
29,426 GBP2021-03-31
21,363 GBP2020-03-31
Debtors
Current, Amounts falling due within one year
203,272 GBP2021-03-31
238,931 GBP2020-03-31
Trade Creditors/Trade Payables
Current
190,089 GBP2021-03-31
216,964 GBP2020-03-31
Amounts owed to group undertakings
Current
75,976 GBP2021-03-31
80,200 GBP2020-03-31
Corporation Tax Payable
Current
6,496 GBP2021-03-31
0 GBP2020-03-31
Creditors
Current
272,561 GBP2021-03-31
297,164 GBP2020-03-31

  • ROSEBANK PHARMA LIMITED
    Info
    Registered number 08753377
    Rosebank Surgery, Ashton Road, Lancaster LA1 4JS
    Private Limited Company incorporated on 2013-10-29 and dissolved on 2024-01-09 (10 years 2 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.